These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 3554800)

  • 1. [Controlled study of increasing venous tone in primary varicose veins by oral administration of Ruscus aculeatus and trimethylhespiridinchalcone].
    Weindorf N; Schultz-Ehrenburg U
    Z Hautkr; 1987 Jan; 62(1):28-38. PubMed ID: 3554800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Varicose vein drugs--new attempts at objectivation of the effects of therapy].
    Marshall M
    Fortschr Med; 1984 Aug; 102(29-30):772-4. PubMed ID: 6500447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Improving venous tone and capillary sealing. Effect of a combination of Ruscus extract and hesperidine methyl chalcone in healthy probands in heat stress].
    Rudofsky G
    Fortschr Med; 1989 Jun; 107(19):52, 55-8. PubMed ID: 2668140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of extract of Ruscus aculeatus in venous disease in the lower limbs.
    Cappelli R; Nicora M; Di Perri T
    Drugs Exp Clin Res; 1988; 14(4):277-83. PubMed ID: 3048951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of a drug combination on venous capacity].
    Rudofsky G; Nobbe F
    Fortschr Med; 1982 Jul; 100(25):1217-20. PubMed ID: 7106687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and capillaroscopic evaluation in the treatment of chronic venous insufficiency with Ruscus aculeatus, hesperidin methylchalcone and ascorbic acid in venous insufficiency treatment of ambulatory patients.
    Aguilar Peralta GR; Arévalo Gardoqui J; Llamas Macías FJ; Navarro Ceja VH; Mendoza Cisneros SA; Martínez Macías CG
    Int Angiol; 2007 Dec; 26(4):378-84. PubMed ID: 18091707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Venous constriction by local administration of ruscus extract].
    Berg D
    Fortschr Med; 1990 Aug; 108(24):473-6. PubMed ID: 2227746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of a Butcher's broom preparation (Ruscus aculeatus L. extract) compared to placebo in patients suffering from chronic venous insufficiency.
    Vanscheidt W; Jost V; Wolna P; Lücker PW; Müller A; Theurer C; Patz B; Grützner KI
    Arzneimittelforschung; 2002; 52(4):243-50. PubMed ID: 12040966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of life improvement in Latin American patients suffering from chronic venous disorder using a combination of Ruscus aculeatus and hesperidin methyl-chalcone and ascorbic acid (quality study).
    Guex JJ; Avril L; Enrici E; Enriquez E; Lis C; Taïeb C
    Int Angiol; 2010 Dec; 29(6):525-32. PubMed ID: 21173734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are the phlebotonic properties shown in clinical pharmacology predictive of a therapeutic benefit in chronic venous insufficiency? Our experience with Daflon 500 mg.
    Tsouderos Y
    Int Angiol; 1989; 8(4 Suppl):53-9. PubMed ID: 2698902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Experiences in the use of Essaven capsules in the treatment of venous leg diseases. Results of a double-blind study].
    Neumann-Mangoldt P
    Fortschr Med; 1979 Dec; 97(45):(2117-9). PubMed ID: 391678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of a phlebotonic agent].
    Thebault JJ
    Fortschr Med; 1983 Jul; 101(25):1206-12. PubMed ID: 6350133
    [No Abstract]   [Full Text] [Related]  

  • 13. Controlled studies of Daflon 500 mg in chronic venous insufficiency.
    Geroulakos G; Nicolaides AN
    Angiology; 1994 Jun; 45(6 Pt 2):549-53. PubMed ID: 8203786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between improvement in functional signs and plethysmographic parameters during venoactive treatment (Cyclo 3 Fort).
    Allaert FA; Hugue C; Cazaubon M; Renaudin JM; Clavel T; Escourrou P
    Int Angiol; 2011 Jun; 30(3):272-7. PubMed ID: 21617611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Venous tone: are the phlebotonic properties predictive of a therapeutic benefit? A comprehensive view of our experience with Daflon 500 mg.
    Tsouderos Y
    Z Kardiol; 1991; 80 Suppl 7():95-101. PubMed ID: 1792820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Conservative and surgical measures in phlebologic consulatation. Report on the potassium-neutral venous diuretic Dehydro-sanol-tri].
    Wissniowski T; Harlin-Wissniowski A
    Fortschr Med; 1974 Oct; 92(28):1132-7. PubMed ID: 4616896
    [No Abstract]   [Full Text] [Related]  

  • 17. Combination of Ruscus aculeatus extract, hesperidin methyl chalcone and ascorbic acid: a comprehensive review of their pharmacological and clinical effects and of the pathophysiology of chronic venous disease.
    Allaert FA
    Int Angiol; 2016 Apr; 35(2):111-6. PubMed ID: 26928296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of the therapeutic effect of a phlebotropic drug with a new noninvasive method: rheography by reflected light].
    Tumino G; Berni A; Tromba L; Marignetti L
    Clin Ter; 1987 Aug; 122(3):189-94. PubMed ID: 2973911
    [No Abstract]   [Full Text] [Related]  

  • 19. Meta-analysis of clinical trials of Cyclo 3 Fort in the treatment of chronic venous insufficiency.
    Boyle P; Diehm C; Robertson C
    Int Angiol; 2003 Sep; 22(3):250-62. PubMed ID: 14612852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of horse-chestnut seed extract on transcapillary filtration in chronic venous insufficiency].
    Bisler H; Pfeifer R; Klüken N; Pauschinger P
    Dtsch Med Wochenschr; 1986 Aug; 111(35):1321-9. PubMed ID: 3527643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.